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DOI: http://dx.doi.org/10.1016/j.hemonc.2014.01.002AIM OF THE STUDY: To evaluate the psychological morbidity of acute lymphoblastic leukemia (ALL) on
children and their parents at different stages of illness and to assess the crucial contribution of the psychologist
in the pediatric oncology team.
METHODS: We recruited 103 children with ALL and their 96 parents, and divided them into five groups
according to disease phase: diagnosis, initial remission, active treatment, survival and relapsing. We compared
these to 22 healthy controls and their parents. Patients and controls were subjected to clinical assessments, the
symptoms checklist of the International Classification of Disease ICD (ICD-10), and the Wechsler Intelligence
Scale for Children The parents of patients and controls underwent a general health questionnaire, the ICD-10
symptoms checklist, rating scales for anxiety and depression, post-traumatic stress disorder (PTSD) assessment
scale, and the physical cognitive affective social economic ego problems (PCASEE) questionnaire for quality
of life (QOL) rating.
RESULTS: Psychiatric morbidity was evident in nearly 60% of leukemic children and their parents and was sig-
nificantly increased in comparison to controls. Children mostly suffered from adjustment and oppositional defi-
ant disorders. The most common discriminators between patient groups were conduct and attention problems
being lowest in newly diagnosed patients, and social aggression being lowest in patients in remission. The three
parameters were highest in relapsed patients whose parents mostly had adjustment and depressive disorders.
Risk factors for child psychopathology were older age, female gender, and parental psychopathology. Mothers
and parents with lower education and professional level were found to be vulnerable. Performance and total
intelligence quotient (IQ) were significantly lower in leukemic children, and these were most pronounced in
the survivor group. Risk factors for cognitive dysfunction were younger age, longer chemotherapy duration,
and lower parental education level.
CONCLUSION: Most patients and their caregivers suffered from significant psychiatric morbidity, highlighting
the need for routine screening to improve psychological outcomes in such cases.The remarkable history of treatment success inchildhood cancer over the past 30 years haschanged the landscape for psychosocial
oncology care.1 As pediatric patients and their parents
learn of a cancer diagnosis and embark on an often
lengthy and intensive course of treatment, they are
at increased risk for new or exacerbated psychosocialHemadifﬁculties.2 Psychiatric morbidity can adversely affect
patients in many ways. It can impair quality of life,3
functional status,4 and energy level;5 it can increase
symptom burden and pain intensity,6 and interfere
with medical treatment.7,8
Providing comprehensive care to pediatric oncology
patients and their families necessitates the integrationtol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.com
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of multidisciplinary psychosocial teams, interventions
into treatment plans, and an increased presence of
psychologists.9
In the pediatric oncology setting, children diagnosed
with acute lymphoblastic leukemia (ALL) and their
caregivers may be at higher risk of difﬁculties related
to this signiﬁcant stressor. Little is known about psy-
chological distress in cultures outside of North Amer-
ica and Europe. Differences in treatment, the limited
availability of psychosocial care, and/or family culture
may inﬂuence how distress is perceived and managed.
Through trained psychologists as part of a pediat-
ric oncology team, we aimed to assess the psycholog-
ical morbidity of ALL in both diseased children and
their parents at various stages of the illness.SUBJECTS AND METHODS
One hundred and three children with acute lympho-
blastic leukemia and their 96 parents, diagnosed and
treated in the Pediatric Hematology/Oncology Unit,
Children’s Hospital, Ain Shams University, Cairo,
Egypt, were recruited. Only patients and/or their
attending parents who gave their verbal informed con-
sent were included. The study protocol was approved
by the Institutional Review Board at Children’s Hospi-
tal, Ain Shams University. Initially, 200 patients were
recruited over an 18-month period, but 49 patients
were excluded because patients and/or parents refused
to complete the interview and/or questionnaires. An-
other 45 patients were excluded due to poor clinical
condition of the child (severe pain, non-cooperation,
irritability or due to the child’s disturbed conscious-
ness), and another three patients were dismissed due
to the presence of co-morbidity with Down syndrome.
The studied patients were 60 males and 43 fe-
males, aged 10 ± 2.4 years. They were divided into
ﬁve groups according to their disease phase: Group
I (GP I): 21 patients at initial diagnosis (less than
one week of diagnosis); Group II (GP II): 21 patients
in initial complete remission (within three months of
diagnosis); Group III (GP III): 22 patients in main-
tained complete remission for one year or more but
still under anti-leukemia therapy; Group IV(GP
IV): 28 relapse free survivors (off therapy for at least
two years); Group V (GP V): 11 patients in bone
marrow relapse (patients with central nervous system
(CNS) relapse were excluded).
The group of parents studied included the parent
who was continuously with the child during therapy
sessions and admissions. These included the mothers
of 71 children and the fathers of 25 children; seven
parents refused psychological assessment. OnlyHematol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.coparents who were above 20 years of age and free of
any premorbid psychiatric conditions were recruited.
Controls were recruited from non-medical univer-
sity workers and their school children who were com-
parable to patients in relation to socio-economic
conditions and had no history of chronic illness. Leu-
kemia patients were compared to 22 healthy controls
comparable in age (mean 10.4 ± 3.8 years; P > 0.05)
and sex (female = 10; male = 12; P > 0.05). Their
22 care-giving parents were comparable to patients’
parents in age (mean 36 ± 8 years), sex (16 females
and six males) and education levels.METHODS
I. Both the patients and controls were subjected to the
following:m Thorough clinical history and examination
 Psychiatric interviews and assessments were con-
ducted by trained qualiﬁed psychologist using the
following instruments:
(1) Semi-structured psychiatric interview acc-
ording to the International Classiﬁcation
of disease (ICD-10), a screening tool for
psychiatric disorders.10 Psychologists were
blind as to why controls were being
interviewed.
(2) Wechsler Intelligence Scale III:11 Verbal
and performance subtests were applied to
assess three areas: verbal comprehension
(comprehension, similarities); perceptual
organization (picture completion, block
design) and freedom from distractibility
(arithmetic, digit span, digit coding).
(3) Children’s Manifest Anxiety (CMA)12 in
the Arabic version,13 a child self-report
measure that assesses symptoms of anxiety
for those above seven years of age. It con-
sists of 36 statements and measures six
aspects of anxiety (somatic, physiological,
motor, emotional, mental, social features),
with six statements for each aspect.
(4) Children’s Depression Inventory (CDI)14
in the Arabic version,15 a 27-item self-
report that assesses mood symptoms for
those above seven years of age.
(5) The Revised Behavior Problem checklist
(RBPC),16 a family self-rated instrument
that surveys a broad range of difﬁculties
encountered in children from preschool
age through to adolescence, and which
provides six scales: conduct disorder, soc-
ialized aggression, anxiety withdrawal, m-
otor tension excess, attention problems,
immaturity, and psychotic disorders.77
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II Parents of both leukemic children and healthy con-
trols were subjected to psychiatric interviews and
assessment by trained qualiﬁed psychologists using
the following instruments:(1) General health questionnaire (GHQ)17 in the
Arabic version,18 a 28-item screening tool for
psychiatric illnesses. It includes four elements:
scale A (somatic symptoms), scale B (anxiety
and insomnia), scale C (social dysfunctions),
and scale D (severe depression).
(2) Semi-structured psychiatric interviews accord-
ing to the international classiﬁcation of disease
ICD-10 Symptoms Checklist of Mental
Disorders.19
(3) Hamilton Anxiety Rating Scale (ham-a),20 in
the Arabic version.21 This scale assesses both
somatic and cognitive anxiety. There are 14
items, each of which is rated 0–4 on an unan-
chored severity scale. A score of 14 or more
has been suggested as the threshold for clini-
cally signiﬁcant anxiety.
(4) Hamilton Checklist of Symptoms of Depres-
sive Illness (ham-d),22 in the Arabic version.23
The scale monitors the severity of major
depression, with focus on somatic symptom-
atology. It is a 17-item scale, with scores from
0 to 4. A score of 10 is suggested as the thr-
eshold for clinically signiﬁcant depressive
symptoms.
(5) Post-traumatic stress disorder (PTSD) asse-
ssment scale.24 This is a questionnaire com-
prising 30 questions. Each item on the post-
traumatic assessment scale is scored from 0
to 4.
(6) The PCASEE Questionnaire for Quality of
Life (QOL).25 The questionnaire measures
P (physical problems), C (cognitive prob-
lems), A (affective problems), S (social prob-
lems), E (economic), and E (ego problems).
Each subtest is placed in a separate column.
The sum of each column is multiplied by ﬁve
to give a percentage score, in which 100% sig-
niﬁes the best quality of life.Psychiatric morbidity was diagnosed if patients,
controls or their caregivers fulﬁlled the diagnostic cri-
teria of any of the psychiatric interview / assessment
tools used in the studySTATISTICAL ANALYSIS
Data were coded and analyzed using the statistical
package SPSS version 6. The descriptive statistics
were expressed as mean and standard deviation. TheHemaanalytic statistic used the student’s T-test, the linear
regression analysis, the Kruskal–Wallis test, and the
logistic regression analysis. The level P < 0.05 was
the cut-off value for signiﬁcance.RESULTS
Psychiatric morbidity was present in 58% of the stud-
ied patients (60 patients), mainly adjustment disor-
ders (16 patients) and oppositional deﬁant disorders
(11 patients). Psychiatric morbidity was signiﬁcantly
higher in comparison to controls, and the difference
was most pronounced in patients in Groups II, IV,
V (P < 0.001) (Table 1).
Each of the scales applied RBPC, CMA and CDI
to compare patient subgroups with each other. There
was signiﬁcant elevations of conduct scale and atten-
tion problems in most subgroups in comparison to
Group I (GPI); while socialized aggression is signiﬁ-
cantly lower in GP II in comparison to GP III and
GP IV (Table 2). There was no signiﬁcant difference
between the different subgroups regarding CMA and
the CDI.
The most pronounced effects on cognitive func-
tions were observed in the survivor group who
showed signiﬁcantly lower verbal, performance and
total IQ compared to controls. Moreover, newly diag-
nosed patients showed signiﬁcantly lower perfor-
mance and total IQ (Table 3).
Comparison of different patient subgroups regard-
ing verbal IQ (VIQ), performance IQ (PIQ) and total
IQ (TIQ) was not signiﬁcant except for survivor
group who showed signiﬁcant reduction of the VIQ
compared to GPIII (T = 2.89, P < 0.01). Survival
patients showed signiﬁcant reduction in arithmetic
ability compared to GPIII (T = 3, P < 0.01) and
GPV (T = 2.36, P < 0.01), as well as in similarity
subsets in comparison to GPII (T = 2.8, P < 0.01)
and GPIII (T = 3.1, P < 0.01).
Caregivers mostly suffered from adjustment (22
parents) and depressive disorders (21 parents). Care-
givers were more vulnerable to psychiatric morbidity
than parent controls (P < 0.001), except for parents
of Group III (P > 0.05) (Table 4). Parents of GP
III showed signiﬁcantly lower scoring in the general
health questionnaire (GHQ) in comparison to G PI
(T = 2.6, P < 0.01) and GP II (T = 2.7, P < 0.01),
and signiﬁcantly lower Hamilton Anxiety Rating
Scale (ham-a) and Hamilton Checklist of Symptoms
of Depressive Illness (ham-d) in comparison to
GPV (T = 2.42, P < 0.01) and (T = 3.49,
P < 0.01), respectively.tol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.com
Table 1. Psychiatric diagnosis in different patient groups.
Diagnosis GP I GP II GP III GP IV GP V All groups Controls
Adjustment disorder 6 7 3 16 2
Separation anxiety 1 3 4 1
Generalized anxiety disorder 1 4 1 6
Post-traumatic stress disorder 4 1 5
Steroid induced anxiety 1 1
Drug induced anxiety 1 1
Moderate depression 2 2 4
Drug induced depression 3 3
Oppositional defiant disorder 1 5 4 1 11 1
Oppositional defiant disorder with other disorder 1 1 3 2 7
Mild cognitive disorder* 1 1
Mild cognitive disorder-moderate depression 1 1
Total number (%) 8 (38%) 13 (61%) 12 (57%) 18 (64%) 9 (81%) 60 (58%) 4 (18%)
Z-value (P value) 2 (P < 0.01) 3.2 P < 0.001) 2.5 (P < 0.01) 3.7 (P < 0.001) 3.5 (P < 0.001) 3.7 (P < 0.001)
GP I: At diagnosis; GP II: After 1st remission; GP III: During maintenance; GP IV: Survivor; GP V: Relapsed.
*Cognitive disorder due to direct physiological effect of medical condition that does not meet criteria for any specific conditions.
PSYCHOLOGICAL MORBIDITY OF ALL original research reportDISCRIMINATIVE ANALYSIS
The Kruskal–Wallis test was applied to identify
parameters that can best discriminate psychological
health between the ﬁve subgroups. The test revealed
that conduct scale (probability = 0.042, H = 9.9),
socialized aggression (probability = 0.02, H = 11.4),
and attention problems (probability = 0.05, H = 8.9)
were the most discriminators in relation to the
psychological test. Similarities (probability = 0.05,
H = 9.29) and arithmetic ability (probability = 0.02,
H = 11.4) were the most discriminators regarding
cognitive functions. In terms of parental psychological
health, the general health questionnaire (probabil-
ity = 0.03, H = 10) and the Hamilton Checklist
of Symptoms of Depressive Illness (probabil-
ity = 0.01, H = 11.6) held the most discriminating
parameters.RISK FACTORS FOR COGNITIVE/
PSYCHOLOGICAL DISEASE IN PATIENTS
AND PARENTAL TREATMENT AND
DISEASE-RELATED FACTORS
There was signiﬁcant negative correlation between the
duration of chemotherapy and aspects of cognitive
functions, including block design in patients onHematol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.comaintenance therapy (GP III) (r = 0.69;
P < 0.05); similarity (r = 0.457; P < 0.05), and
picture completion (r = 0.458; P < 0.05) in survi-
vors (Gp IV). However, there was no signiﬁcant cor-
relation between chemotherapy duration and VIQ,
PIQ, and TIQ in all groups.
Radiotherapy was not associated with signiﬁcant
effect on cognitive functions. Time since irradiation
was not correlated to cognitive functions in survivors
(Group IV).PATIENT-RELATED FACTORS
There was a signiﬁcant positive correlation between
the age of the child at the time of study evaluation
and the anxiety withdrawal (r = 0.49; P = 0.02),
CMA (r = 0.66; P < 0.001) and CDI (r = 0.57;
P = 0.005) in Group III during maintenance therapy.
Further, there was a signiﬁcant positive correlation
between the age at the beginning of leukemia treat-
ment and CMA (r = 0.51; P = 0.015) and CDI
(r = 0.53; P = 0.011) in Group III patients. There
was a signiﬁcant positive correlation between the age
at the beginning of treatment and digit span
(r = 0.49; P = 0.008); block design (r = 0.62;
P < 0.001); performance (r = 0.74; P < 0.001), and
total IQ (r = 0.61; P < 0.001) in survivors.m 79
Table 2. Comparison between patient subgroups with each other in relation to the Revised Behavior Problem Checklist (RBPC):
RBPC ITEM score (mean € SD) GP I T-value GP II T-value GP III T-value GP IV T-value
Conduct GP I (10 € 8.6) GP II (16.8 € 9) GPIII (17.2 € 9) GP IV (17.7 € 1.8)
GP II (16.8 € 9) 2.44** – 0.15 0.1
GP III (17.2 € 9) 2.5* 0.15 – 0.04
GP IV (17.7 € 1.8) 2.2** 0.1 0.04 –
GP V (22 € 12) 2.68** 1.16 1.07 1.04
Anxiety withdrawal GP I (6.2 € 4) GP II (7.6 € 4.7) GP III (6.4 € 4.3) GP IV (8.2 € 4.8)
GP II (7.6 € 4.7) 1.06 – 0.82 0.45
GP III (6.4 € 4.3) 0.19 0.82 – 1.29
GP IV (8.2 € 4.8) 1.57 0.45 1.29 –
GP V (10.2 € 5.2) 2.08* 1.29 1.89* 0.98
Attention problems GP I (3.8 € 4.6) GP II (6.8 € 4.8) GP III (7.6 € 7) GP IV (9.7 € 8.4)
GP II (6.8 € 4.8) 2* – 0.46 1.44
GP III (7.6 € 7) 2.08* 0.46 – 0.72
GP IV (9.7 € 8.4) 2.9** 1.44 0.9 –
GP V (8.8 € 8) 1.75* 0.72 0.39 0.28
Socialized aggression GP I (1.8 € 1.9) GP II (0.95 € 1) GP III (2.7 € 2.1) GP IV (2.3 € 2.2)
GP II (0.95 € 1) 1.8* – 3.34** 2.56**
GP III (2.7 € 2.1) 1.33 3.34** – 1.61
GP IV (2.3 € 2.2) 0.69 2.56** 0.61 –
GP V (3.3 € 3.1) 1.3 2.2* 0.54 0.89
Psychotic behavior GP I (0.57 € 1) GP II (0.6 € 0.9) GP III (1.1 € 1.2) GP IV (1.3 € 1.7)
GP II (0.6 € 0.9) 0.3 – 1.4 1.7*
GP III (1.1 € 1.2) 1.54 1.4 – 0.55
GP IV (1.3 € 1.7) 1.84* 1.7* 0.55 –
GP V (1.3 € 2) 1.07 0.95 0.26 0.08
GP I: At diagnosis; GP II: After 1st remission; GP III: During maintenance; GP IV: Survivor; GP V: Relapsed.
*Significance at P < 0.05.
**Significance at P < 0.01.
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P < 0.01), block design (T = 2.15, P < 0.05), digit
symbol (T = 4.41, P < 0.001), and performance IQ
(T = 1.77, P < 0.05) were signiﬁcantly lowered in
the group who received irradiation before the age of
ﬁve years compared to patients given irradiation at
an older age.HemaThere was signiﬁcant elevation of the total scores
of RBPC (T = 2, P < 0.05) and the conduct scale
(T = 1.9, P < 0.05) in females compared to males
of Group I, but there was no signiﬁcant difference be-
tween males and females in Groups III and IV in rela-
tion to both psychological and cognitive functions
(T < 1.4; P > 0.05) for all parameters.tol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.com
Table 3. Comparison between patient groups and controls regarding VIQ (Verbal IQ), PIQ (Performance IQ) and the TIQ (Total IQ).
Group VIQ patients VIQ controls T-value P-value
GP I 109 € 13 115 € 12 1.5 >0.05
GP II 105 € 5.8 1.7 >0.05
GP III 112 € 5.8 0.6 >0.05
GP IV 102 € 11.5 2.4 <0.01
GP V 110 € 19 0.6 >0.05
All groups 107 € 13 0.6 >0.05
Group PIQ patients PIQ controls T-value P-value
GP I 94.8 € 18 2.6 <0.01
GP II 101 € 6 1.7 >0.05
GP III 99 € 12.8 2.2 <0.05
GP IV 100 € 13.7 2.1 <0.05
GP V 103 € 16.2 1.4 >0.05
All groups 98 € 14.3 2.8 <0.01
Group TIQ patients TIQ controls `T' P-value
GP I 100 € 18 114 € 12 2.9 <0.01
GP II 110 € 17 1.6 >0.05
GP III 105 € 13 1.7 >0.05
GP IV 100 € 13 3.8 <0.001
GP V 105 € 15 1.4 >0.05
All groups 102 € 15 3.9 <0.001
GP I: At diagnosis; GP II: After 1st remission; GP III: During maintenance; GP IV: Survivor; GP V: Relapsed.
Table 4. Psychiatric diagnosis in parental groups according to child's disease phase.
Diagnosis GP I GP II GP III GP IV GP V All groups Controls
Adjustment disorder 10 6 2 1 3 22 2
Moderate depression 5 6 2 3 2 18
Severe depression 2 1 3
Persistent mood disorder 2 1 2 5 1
Generalized anxiety disorder 1 4 1 6
Post-traumatic stress disorder 1 1
Somatization disorder 1 1
Schizotypal disorder 1 1
Total number (%) 15 (71%) 14 (66%) 7 (33%) 13 (56%) 8 (80%) 57 (59%) 3 (13%)
Z-value (P value) 3.8 (P < 0.001) 3.5 (P < 0.001) 1.4 (P > 0.05) 3 (P < 0.001) 3.6 (P < 0.001) 3.8 (P < 0.001)
GP I: At diagnosis; GP II: After 1st remission; GP III: During maintenance; GP IV: Survivor; GP V: Relapsed.
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There was signiﬁcant elevation of all the studied psy-
chological parameters in mothers of Group IV (survi-
vors) compared to the fathers in the same group,
including GHQ (T = 5.8; P < 0.001), Hamilton
depression (T = 5.3; P < 0.001), anxiety (T = 5.65;
P < 0.001), QOL (T = 4.46; P < 0.001), and PTSD
assessment (T = 5.2; P < 0.001).
There was signiﬁcant negative correlation between
professions and the education levels of parents within
the parameters of GHQ (r = 0.68 & 0.65; P < 0.05),
Ham-anxiety (r = 0.68 & 0.7; P < 0.05), Ham-
depression (r = 0.68 & 0.75; P < 0.05), QOL
(r = 0.57 & 0.49; P < 0.05), and PTSD assessment
(r = 0.5 & 0.061; P < 0.05), in the parents of chil-
dren of Group III (during maintenance therapy).
Both education levels and professions of parents had
a signiﬁcant positive correlation within the perfor-
mance IQ (r = 0.6; P = 0.002), total IQ (r = 0.6;
P = 0.002), block design (r = 0.59; P = 0.003), and
digit symbol (r = 0.69; P < 0.001) of survivor pa-
tients (Group IV).DISCUSSION
The diagnosis and intense endurance demands of
treatment for childhood cancer has a tremendous
and lasting effect on the patients, their families, and
other individuals in their social network.26 Although
national and international recommendations for com-
prehensive care emphasize the importance of psycho-
social services,27 the psychosocial care provided to
children and families is not standardized, and is often
variable between institutions and even within
settings.1
The high prevalence of psychological morbidity de-
tected in both patients and their parents in our study
reﬂects the importance of psychological screening
assessments and the crucial role of psychologists’ con-
tributions in the pediatric oncology team. Higher
prevalence (77%) was reported in a previous Egyptian
study,28 despite similar cultural factors. However, the
inclusion of different types of cancer and inferior out-
comes of the disease at that time could account for
this difference.
Several exceptional themes appear when exploring
psychiatric morbidity by disease phase. Phases that
were distinguished in our study were the diagnostic
phase, initial treatment phase, active treatment phase,
maintenance phase, survival, and relapsing stage.
In newly diagnosed patients (GP I) in the ﬁrst
week of diagnosis and before the introduction ofHemachemotherapy, 42% showed psychiatric morbidity,
most suffering from anxiety and possibly the impact
of hospitalization and separation from other siblings.
In the ﬁrst three months of diagnosis and with the
introduction of therapy, psychiatric morbidity in-
creased in patients to a prevalence of 61%, most suf-
fering from adjustment disorders. In contrast,
patients who maintained their ﬁrst remission for more
than one year suffered mainly from oppositional deﬁ-
ant disorder. Even survivors who were relapse-free for
over two years had psychiatric morbidity prevalence of
64%, suffering mostly from stress-related disorders.
The highest psychiatric morbidity (80%) was ob-
served in relapsed patients, who suffered mostly from
adjustment disorder and oppositional deﬁant disor-
der. The impact of hospitalization, body disﬁgure-
ment (alopecia, Cushingoid facies), and disturbed
peer relationships, could be factors causing a recogniz-
able source of childhood anxiety disorders.29
The most common discriminators between patient
groups were conduct and attention problems which
were lowest in newly diagnosed patients, and social
aggression which was lowest in patients in remission.
The three parameters were highest in relapsed pa-
tients. These ﬁndings may indicate that the most
common reaction of those children in the face of trau-
ma is the increase of antisocial behavior. Verbal sim-
ilarity and arithmetic ability were good discriminators
between different patient subgroups; these two
parameters tended to be lowest in the survival group,
which could indicate signiﬁcant cognitive decline spe-
ciﬁcally in survival patients.
Diagnosis of childhood cancer is one of the most
emotional experiences that parents face, and when
they are confronted with the diagnosis of cancer in
their child, a psychological stress process starts30
and its outcome is generally referred to as adjust-
ment.31 Our study observed that adjustment disorders
were more prevalent in parents whose children were
newly diagnosed or relapsed, whereas depressive dis-
orders were more prevalent in parents during the
maintenance phase of therapy.
There is a broad array of risk factors and vulnera-
bilities associated with intense and persistent distress
for families of children with cancer. Assessment of
risk factors is critical to the delivery of psychosocial
care matched to the needs of children and families
across the course of treatment as it reduces the likeli-
hood of poorer child and family psychosocial out-
comes.2 When we studied certain risk factors, we
found that female patients were more vulnerable for
behavior and conduct problems, and that younger pa-
tients suffered more from anxiety and depression. Wetol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.com
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recorded a signiﬁcant negative correlation between the
duration of chemotherapy and some aspects of cogni-
tive functions. However, there was no signiﬁcant dif-
ference regarding cognitive functions in irradiated
versus non-irradiated patients. The digit span, block
design, digit symbol, and IQ performance were signif-
icantly lower in patients who received irradiation be-
low the age of ﬁve years.
Stress reactions can take different forms in fathers
and mothers, and it may be relevant to identify these
differences in order to deliver speciﬁc interventions.
We reported that mothers of survival patients had sig-
niﬁcant elevation of all psychological parameters in
comparison to the fathers. These differences may be
related to the traditional Egyptian distribution of
care-giving tasks and responsibilities, and to the fact
that mothers spend more time in hospital with their
children. Another possibility is that women seem
more willing to report discomfort than men.32
Certain demographic traits have been identiﬁed as
risk factors for parents of children with cancer: those
who were less educated and parents with lower pro-
fession levels were more susceptible for psychiatric
morbidity and showed more anxiety, depression, and
post-traumatic stress symptoms. This is in agreement
with other researchers who highlighted the impact of
education and professional level.33,34 One Egyptian
study35 reported higher parent psychiatric morbidity
(82%), but parents with a high level of education in
that study were only 8%, compared to 27% in our
study.
The goal of assessing the level of family risk is to
build an optimal ﬁt between patient/family needs
and psychosocial care, provide good preventative pa-
tient care, and present an efﬁcient and cost-effective
approach to the allocation of resources within the
health care environment.36 Interventions at theHematol Oncol Stem Cell Ther 7(2) Second Quarter 2014 hemoncstem.edmgr.coclinical level are the most intensive and expensive,
and are most often focused on meeting the signiﬁcant
needs of patients and families with multiple pre-
existing difﬁculties.1 Screening provides the means
to determine patients and parents at highest risk,
and those requiring follow up, support and early
intervention.2 The use of routine distress screening
by inpatient cancer services can signiﬁcantly improve
the capacity to offer psychosocial care.37LIMITATIONS OF THE STUDY
The high dropout rate observed in relation to 49 pa-
tients/parents refusing to complete interviews and/or
questionnaires for this study may reﬂect a perception
that psychological assessment is less essential than
medical evaluations and interventions. This may re-
ﬂect a lack of cultural awareness of the importance
of psychological support in cancer health care. The
inclusion of children at various stages of treatment
within one sample (diagnosis through survivorship)
develops the challenge that the ﬁve subgroups divide
the sample into small groups.CONCLUSION
Pediatric cancer patients and their care-givers fre-
quently suffer from signiﬁcant psychiatric morbidity.
The need for routine psychological screening to im-
prove the psychological outcomes of those patients
and their parents is vital to the improvement of their
quality of life.CONFLICT OF INTEREST
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